Kelly CP - Search Results

1

Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.

Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, Pasetti MF, Feng H. Yu H, et al. Among authors: kelly cp. Clin Vaccine Immunol. 2017 Aug 4;24(8):e00037-17. doi: 10.1128/CVI.00037-17. Print 2017 Aug. Clin Vaccine Immunol. 2017. PMID: 28592627 Free PMC article.

2

Immune response to Clostridium difficile infection.

Kelly CP. Kelly CP. Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1048-53. doi: 10.1097/00042737-199611000-00004. Eur J Gastroenterol Hepatol. 1996. PMID: 8944364 Review.

3

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.

Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, Kelly CP. Salcedo J, et al. Among authors: kelly cp. Gut. 1997 Sep;41(3):366-70. doi: 10.1136/gut.41.3.366. Gut. 1997. PMID: 9378393 Free PMC article.

4

Clostridium difficile infection.

Kelly CP, LaMont JT. Kelly CP, et al. Annu Rev Med. 1998;49:375-90. doi: 10.1146/annurev.med.49.1.375. Annu Rev Med. 1998. PMID: 9509270 Review.

5

Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.

Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, Nikulasson ST, LaMont JT, Pothoulakis C. Castagliuolo I, et al. Among authors: kelly cp. J Immunol. 1998 Jun 15;160(12):6039-45. J Immunol. 1998. PMID: 9637520

6

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Kyne L, Warny M, Qamar A, Kelly CP. Kyne L, et al. Among authors: kelly cp. N Engl J Med. 2000 Feb 10;342(6):390-7. doi: 10.1056/NEJM200002103420604. N Engl J Med. 2000. PMID: 10666429 Free article.

7

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Kyne L, Warny M, Qamar A, Kelly CP. Kyne L, et al. Among authors: kelly cp. Lancet. 2001 Jan 20;357(9251):189-93. doi: 10.1016/S0140-6736(00)03592-3. Lancet. 2001. PMID: 11213096

8

Clostridium difficile.

Kyne L, Farrell RJ, Kelly CP. Kyne L, et al. Among authors: kelly cp. Gastroenterol Clin North Am. 2001 Sep;30(3):753-77, ix-x. doi: 10.1016/s0889-8553(05)70209-0. Gastroenterol Clin North Am. 2001. PMID: 11586556 Review.

9

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.

Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Kyne L, et al. Among authors: kelly cp. Infect Control Hosp Epidemiol. 2002 Nov;23(11):653-9. doi: 10.1086/501989. Infect Control Hosp Epidemiol. 2002. PMID: 12452292

10

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.

Aboudola S, Kotloff KL, Kyne L, Warny M, Kelly EC, Sougioultzis S, Giannasca PJ, Monath TP, Kelly CP. Aboudola S, et al. Among authors: kelly ec, kelly cp. Infect Immun. 2003 Mar;71(3):1608-10. doi: 10.1128/IAI.71.3.1608-1610.2003. Infect Immun. 2003. PMID: 12595488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters